Advanced prostatic ductal carcinoma in a patient with a long survival time following a total pelvis exenteration: A case report

Oncology Letters
Changwei JiHongqian Guo

Abstract

Ductal adenocarcinoma of the prostate (DAP) is a rare variant of prostate cancer, and has poorly-identified clinical characteristics. Few cases have been previously reported in Chinese males and DAP is more commonly reported in Caucasian males over 70-years of age. In the present study, a 55-year-old Chinese male patient that demonstrated typical lower urinary tract symptoms and normal prostatic-specific antigen levels underwent a transurethral resection of the prostate. The patient was subsequently diagnosed with DAP. A total pelvis exenteration was then conducted successfully. During the 40-month follow-up, the patient remained progression-free. A review of the literature was conducted in order to assess the clinical course, diagnosis, prognosis and optimal management for DAP. The review indicated that DAP is more likely to demonstrate an aggressive clinical course and an unfavorable prognosis; therefore, once the diagnosis has been confirmed, an aggressive management strategy is recommended for the patient, even in the case of metastatic disease.

References

Oct 1, 1967·Cancer·M M Melicow, M R Pachter
Oct 1, 1973·American Journal of Clinical Pathology·J A Carney, P P Kelalis
Mar 28, 2008·Urologic Oncology·Eduardo Orihuela, Justin M Green
Dec 17, 2009·The Journal of Urology·Jonathan I Epstein
Dec 15, 2015·Journal of the National Comprehensive Cancer Network : JNCCN·Peter R CarrollDeborah Freedman-Cass

❮ Previous
Next ❯

Citations

Apr 8, 2021·Nature Reviews. Urology·Weranja RanasingheBrian F Chapin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.